. . . . . "Vortioxetine" . . . "Mood disorder" . . . . . . "The on‐label indication for Brintellix is depression; we identified the following off‐label indications: schizophrenia, episodic mood disorders, anxiety disorders, personality disorders, bipolar depression, post‐traumatic stress disorder, and chronic pain." . . . . . . . "Adults" . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" . "XXjls04rC5qCxClCJZwfe0pqkytGiLGNXXawQG2kiOWMVSBI+QY/gxf4OxfgQfhr9KF/5amAMGYLJpyTG0JfP1asl1zxHkLzCXPGJkUM+NLFom0A5+bw5MSuoU07TAeDyzthRn+8AHwIo9+a6TsfWVuBVG2UzLP0CGgcHp8QvU0=" . . "2022-09-16T11:49:36.567658"^^ . . . "2.3.0" .